An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person wrote that today marks their one-year anniversary using Mounjaro, and they shared their weight change. They say they started around 399 pounds last Halloween, were as heavy as 423 at one point in 2023, and this morning weighed 349. Their records suggest at least 10 inches lost across body measurements, and they’ve noticed non-scale victories (NSVs) — improvements that aren’t just numbers on the scale. Mounjaro is the brand name for tirzepatide. It’s a prescription drug given by injection that acts like two natural gut hormones that help control appetite and blood sugar. In plain terms, it makes many people feel less hungry, helps them feel full sooner, and can slow how quickly the stomach empties after a meal. Doctors prescribe it mainly for people with type 2 diabetes, but it’s also being used off-label for weight loss and is being studied for that purpose. This short post is a personal report, not a scientific study. It’s one person’s real-world experience over a year: roughly a 50-pound drop from about 399 to 349 (and larger from their peak of 423). They also tracked measurements and noticed about 10 inches lost, plus lifestyle or health improvements they called NSVs. Anecdotes like this are useful to see how people respond in daily life, but they don’t tell us how typical the result is, how much of the change came from the drug versus diet, exercise, or other factors, or about side effects the person might have had. For someone curious about Mounjaro, this kind of story shows what’s possible if the medication works well for you: meaningful weight loss and improvements beyond the scale, like fitting into clothes differently or more energy. People with obesity or type 2 diabetes, or those whose doctors recommend it, might pay particular attention. It also highlights why many patients report physical and lifestyle benefits within months of starting medications that affect appetite and blood sugar. Caveats matter. Individual reports don’t replace controlled studies. Tirzepatide can cause side effects such as nausea, diarrhea, constipation, abdominal pain, and low blood sugar when used with other diabetes medicines. Long-term safety and what happens after stopping the drug are still being studied. It’s prescription-only, so anyone considering it should discuss risks, benefits, dosing, and monitoring with a healthcare provider. Bottom line: this post shows a promising personal result, but it’s one story, not proof that everyone will see the same outcome.
Source: r/Mounjaro